Walleye Trading LLC Protagonist Therapeutics, Inc Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$10.78 - $25.38 $602,073 - $1.42 Million	55,851 Added 112.81%	105,360 $2.42 Million
Q4 2022 Feb 14, 2023	BUY	$7.36 - $11.17 $364,386 - $553,015	49,509 New	49,509 $540,000
Q4 2018 Feb 14, 2019	SELL	$6.3 - $10.44 $173,930 - $288,227	-27,608 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.82 - $11.26 $35,757 - $59,036	5,243 Added 23.44%	27,608 $284,000
Q2 2018 Aug 14, 2018	BUY	$5.99 - $9.1 $133,966 - $203,521	22,365 New	22,365 $150,000

247

56.4M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.